Epilepsy clinical trials at UC Davis
1 research study open to eligible people
A Study to Test the Effectiveness and Safety of Experimental Padsevonil for Seizures in Adults With Drug-Resistant Epilepsy
open to eligible people ages 18 years and up
The purpose of the study is to evaluate the efficacy, safety and tolerability of the 3 selected dose regimens of padsevonil (PSL) administered concomitantly with up to 3 anti-epileptic drugs (AEDs) compared with placebo for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy.
Sacramento, California and other locations